ADH1B promotes mesothelial clearance and ovarian cancer infiltration

Primary debulking surgery followed by adjuvant chemotherapy is the standard treatment for ovarian cancer. Residual disease after primary surgery is associated with poor patient outcome. Previously, we discovered ADH1B to be a molecular biomarker of residual disease. In the current study, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Gharpure, Kshipra M., Lara, Olivia D., Wen, Yunfei, Pradeep, Sunila, LaFargue, Chris, Ivan, Cristina, Rupaimoole, Rajesha, Hu, Wei, Mangala, Lingegowda S., Wu, Sherry Y., Nagaraja, Archana S., Baggerly, Keith, Sood, Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754/
https://www.ncbi.nlm.nih.gov/pubmed/29861857
http://dx.doi.org/10.18632/oncotarget.25344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982754/
https://www.ncbi.nlm.nih.gov/pubmed/29861857
http://dx.doi.org/10.18632/oncotarget.25344

Ejemplares similares